PLX-200

PLX-200 · Polaryx Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PLX-200, covering 2025-05-30 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3 [Phase 3]